Published in

American Society for Clinical Pathology, Pathology Patterns Reviews, suppl_1(118), p. S3-S17, 2002

DOI: 10.1309/c1j4-xug0-gm0r-wjay

Links

Tools

Export citation

Search in Google Scholar

Tuberculosis Advances in Laboratory Diagnosis and Drug Susceptibility Testing

Journal article published in 2002 by Quentin Eichbaum, Eric J. Rubin ORCID
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Question mark in circle
Postprint: policy unknown
Question mark in circle
Published version: policy unknown
Data provided by SHERPA/RoMEO

Abstract

Laboratory diagnosis of mycobacterial infection is complicated by the fastidious growth requirements of the bacillus organism. Delays in diagnosis can impede effective treatment and surveillance of the disease. Control of Mycobacterium tuberculosis has also been aggravated by the emergence of multidrug-resistant tuberculosis, and enhanced methods of antibiotic susceptibility testing are needed. Molecular laboratory techniques and advances in rapid culture methods have led to the development of diagnostic and drug susceptibility tests that are rapid and reliable. This article describes recent innovations in the molecular diagnosis and antibiotic susceptibility testing of M tuberculosis.